Their model offered an independent prognostic value (HR = 1664, 1381–2006), with a risk score that was significantly related to the TNM stage, PR, ER, and HER2 status in BC patients [68] (it is ref PMID: 33694315). This evidence concerns the gene ESR1 and breast cancer.